BERNARD L. KASTEN JR. M.D.

Corporate Board Profile

Tech Score: 0/100

SIGA TECHNOLOGIES INC

Filing Date	Source Excerpt
2004-11-22	Bernard L. Kasten Jr. M.D. 58 Director, Chief Executive Officer Bernard L. Kasten Jr., M.D. has been a director of SIGA since May 23, 2003 and became Chief Executive Officer in the third quarter of 2004. His 2004 annual salary is $250,000. In addition, he has been granted options to purchase an aggregate of 2,500,000 shares of common stock of SIGA.
2005-04-29	Bernard L. Kasten Jr., M.D. has been a director of SIGA since May 23, 2003 and became Chief Executive Officer in the third quarter of 2004. Prior to becoming Chief Executive Officer of SIGA and since February 2002, Dr. Kasten had been Vice President, Medical Affairs of MedPlus Inc., a healthcare information technology company and a wholly-owned subsidiary of Quest Diagnostics, Inc., a diagnostic testing, information and services company. Since 1975, Dr. Kasten has been a Diplomat of the American Board of Pathology with a sub-specialty certification in 1976 in Medical Microbiology. Dr. Kasten's staff appointments have included service in the Division of Laboratory Medicine at The Cleveland Clinic; Associate Director of Pathology and Laboratory Services at the Bethesda Hospital Systems in Cincinnati, Ohio and Chief Laboratory Officer at Quest Diagnostics Incorporated. Dr. Kasten was a founder of Plexus Vaccine Inc., a vaccine company of which SIGA acquired substantially all of the assets in May 2003. Dr. Kasten is an author of Infectious Disease Handbook 5th Edition, 2003, Lexi-Comp Inc.

Filing Date

Source Excerpt

2004-11-22

Bernard L. Kasten Jr. M.D. 58 Director, Chief Executive Officer Bernard L. Kasten Jr., M.D. has been a director of SIGA since May 23, 2003 and became Chief Executive Officer in the third quarter of 2004. His 2004 annual salary is $250,000. In addition, he has been granted options to purchase an aggregate of 2,500,000 shares of common stock of SIGA.

2005-04-29

Bernard L. Kasten Jr., M.D. has been a director of SIGA since May 23, 2003 and became Chief Executive Officer in the third quarter of 2004. Prior to becoming Chief Executive Officer of SIGA and since February 2002, Dr. Kasten had been Vice President, Medical Affairs of MedPlus Inc., a healthcare information technology company and a wholly-owned subsidiary of Quest Diagnostics, Inc., a diagnostic testing, information and services company. Since 1975, Dr. Kasten has been a Diplomat of the American Board of Pathology with a sub-specialty certification in 1976 in Medical Microbiology. Dr. Kasten's staff appointments have included service in the Division of Laboratory Medicine at The Cleveland Clinic; Associate Director of Pathology and Laboratory Services at the Bethesda Hospital Systems in Cincinnati, Ohio and Chief Laboratory Officer at Quest Diagnostics Incorporated. Dr. Kasten was a founder of Plexus Vaccine Inc., a vaccine company of which SIGA acquired substantially all of the assets in May 2003. Dr. Kasten is an author of Infectious Disease Handbook 5th Edition, 2003, Lexi-Comp Inc.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-05-29